FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:1135-1136 October 7, 1993 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by John M. Kane and Jeffrey A. Lieberman. 511 pp. New York, Guilford Press, 1992. $60. ISBN 0-89862-885-7.

This book contains a wealth of information of practical importance to all who care for patients suffering from psychiatric disturbances. The editors have organized the contributions of the 44 authors into three sections. The first, entitled "General Issues," includes chapters on the detection of adverse effects in the pre- and post-marketing phases of drug development, abuse liability, drug-drug interactions, and the role of informed consent in clinical psychopharmacology.

The bulk of the material is found in the 21 chapters of the section entitled "Side Effect Profiles of Psychotropic Drugs," with subsections addressing behavioral effects, neuromuscular effects, cardiovascular reactions, seizures, and . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.